FMT to Convert Response to Immunotherapy

NCT05251389 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
24
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Netherlands Cancer Institute